SCIEX ZenoTOF Line Advancements
Analysis based on 9 articles · First reported Jun 01, 2026 · Last updated Jun 01, 2026
The advancements in SCIEX>>>'s ZenoTOF line, a subsidiary of Danaher Corporation>>>, are expected to positively impact the life sciences and diagnostics market by offering more efficient and accurate analytical technologies. This could lead to increased sales and market share for SCIEX>>> and Danaher Corporation>>>, while also benefiting collaborating entities like Trajan Scientific and Medical>>>, Evosep>>>, IonOpticks>>>, BSI Group>>>, MS-DIAL>>>, and MZIO>>> through expanded integration and access to advanced solutions.
SCIEX>>>, a Danaher Corporation>>> company, unveiled significant platform-wide advancements for its ZenoTOF line at ASMS. These updates include the new SCIEX>>> OS 5.0 software with AI-enabled features, expanded front-end compatibility, and key software collaborations. The ZT Scan DIA 3.0 technology enhances data-independent acquisition for proteomics and metabolomics. Integration with the Echo MS+ system makes the ZenoTOF 8600 system the industry's highest-throughput accurate mass platform. Collaborations with Trajan Scientific and Medical>>> for HDX-MS, Evosep>>> and IonOpticks>>> for source enhancements, BSI Group>>> for PEAKS software, MS-DIAL>>> for biomarker discovery, and MZIO>>> for data compatibility aim to reduce workflow complexity and provide deeper insights for omics researchers. Jose Castro-Perez>>> highlighted these innovations as a step change in research capabilities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard